ReNeuron

100 articles about ReNeuron

• ReNeuron: Clinical Advisory Board Appointments

  2/1/2010

• ReNeuron: Regulatory Update

  1/28/2010

• ReNeuron: Regulatory Update

  1/12/2010

• ReNeuron: Interim Results For The Six Months Ended 30 September 2009

  11/30/2009

• ReNeuron Awarded Two Grants Under Regenerative Medicine Funding

  11/30/2009

• ReNeuron Presents Positive Pre-Clinical Efficacy Data With Ren009 Stem Cell Therapy For Peripheral Arterial Disease At Leading US Scientific Conference

  11/16/2009

• ReNeuron to Present ReN001 Stroke Programme at Royal Society of Medicine Briefing

  10/22/2009

• ReNeuron Announces Publication Of New Research Using Rencell(R) Stem Cell Products

  10/2/2009

• ReNeuron Release: 2009 AGM Trading Update

  9/17/2009

• ReNeuron Signs Manufacturing Contract With Angel Biotechnology Ltd For Second-Generation CTX Stem Cell Product

  9/10/2009

• ReNeuron Announces Multiple Peer-Reviewed Journal Publications Regarding Ren001 Stroke Programme

  8/11/2009

• ReNeuron Announces Publication Of Pre-Clinical Data With Its Ren003 Programme For Diseases Of The Retina

  8/10/2009

• ReNeuron Preliminary Results for the Year Ended 31 March 2009

  6/30/2009

• ReNeuron Signs Manufacturing Contract with Angel Biotechnology Ltd To Provide Stem Cells For Stroke Clinical Trial

  6/9/2009

• ReNeuron Release: Final Closing Of The Placing And Capitalisation Of Loan Notes

  5/18/2009

• ReNeuron Successfully Automates Its Stem Cell Manufacturing Process on The Automation Partnership's CompacT SelecT System

  4/30/2009

• ReNeuron Successfully Automates Its Stem Cell Manufacturing Process

  4/9/2009

• ReNeuron Release: Second Closing Of The Placing

  4/7/2009

• ReNeuron Announces Positive Pre-Clinical Data With Lead Stem Cell Line In Peripheral Arterial Disease

  4/6/2009

• ReNeuron: Result of EGM and First Closing of the Placing

  4/3/2009